as on September 13, 2025 at 1:29 am IST
Day's Low
Day's High
0.34%
Downside
4.08%
Upside
52 Week's Low
52 Week's High
34.31%
Downside
71.20%
Upside
Check Beam Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.1B
EPS (TTM)
-4.3004
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-15.47
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
0EBITDA
-424.0M
Revenue (TTM)
60.3M
Profit Margin
0.00%
Return On Equity TTM
147449300.00%
Track how Beam Therapeutics Inc P/E has moved over time to understand its valuation trends.
Beam Therapeutics Inc in the last 5 years
Lowest (0.00x)
September 13, 2025
Today (-15.47x)
September 13, 2025
Industry (10.13x)
September 13, 2025
Highest (0.00x)
September 13, 2025
Today’s Price to Earnings Ratio: -15.47x
Compare market cap, revenue, PE, and other key metrics of Beam Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $2.1B | NA | -15.47 | 0.00% | |
BUY | $61.1B | 280.5% | -505.15 | -12.96% | |
NA | $37.7B | NA | NA | -3.89% | |
BUY | $101.2B | 54.04% | 28.08 | 31.86% | |
BUY | $59.4B | 2.03% | 14.11 | 31.37% |
The Beam Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Beam Therapeutics Inc investment value today
Current value as on today
₹83,428
Returns
Returns from Beam Therapeutics Inc Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 21 analysts
61.90%
Buy
38.10%
Hold
0.00%
Sell
Based on 21 analysts, 61.9% of analysts recommend a 'BUY' rating for Beam Therapeutics Inc. Average target price of $45.92
Get share price movements and forecasts by analysts on Beam Therapeutics Inc.
What analysts predicted
55.16%UPSIDE
Target Price
$45.92
Current Price
$20.59
Analyzed by
21 Analysts
Target
$45.92
Beam Therapeutics Inc target price $45.92, a slight upside of 55.16% compared to current price of $20.59. According to 21 analysts rating.
Investment in Beam Therapeutics Inc Shares on INDmoney has dropped by -52.95% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Beam Therapeutics Inc Stock has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, BEAM stock has moved up by 16.8%
Profit Spike
Netprofit is up for the last 2 quarters, -109.27M → -102.29M (in $), with an average increase of 6.8% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 7.47M → 8.46M (in $), with an average increase of 11.8% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.7% return, outperforming this stock by 187.5%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.7% return, outperforming this stock by 97.4%
Organisation | Beam Therapeutics Inc |
Headquarters | 238 Main Street, Cambridge, MA, United States, 02142 |
Industry | Health Technology |
CEO | Mr. John M. Evans M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Sravan Kumar Emany | Chief Financial Officer |
Dr. Christine P. Bellon J.D., Ph.D. | Senior VP, Chief Legal Officer & Corporate Secretary |
Dr. David R. Liu Ph.D. | Co-Founder |
Dr. Manmohan Singh Ph.D. | Chief Technology Officer |
Dr. Gopi Shanker Ph.D. | Chief Scientific Officer |
Mr. John M. Evans M.B.A. | CEO & Director |
Dr. Giuseppe Ciaramella Ph.D. | President |
Dr. Amy Simon M.D. | Chief Medical Officer |
Dr. Feng Zhang Ph.D. | Co-Founder |
Dr. J. Keith Joung M.D., Ph.D. | Co-Founder |
Beam Therapeutics Inc share price today is $20.59 as on at the close of the market. Beam Therapeutics Inc share today touched a day high of $21.43 and a low of $20.52.
Beam Therapeutics Inc share touched a 52 week high of $35.25 on and a 52 week low of $13.53 on . Beam Therapeutics Inc stock price today i.e. is closed at $20.59,which is 41.59% down from its 52 week high and 52.24% up from its 52 week low.
Beam Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Beam Therapeutics Inc (BEAM) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Beam Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Beam Therapeutics Inc share’s latest price of $20.59 as on September 13, 2025 at 1:29 am IST, you will get 0.4857 shares of Beam Therapeutics Inc. Learn more about
fractional shares .